Asociación del gen TCF7L2 (rs7903146) con marcadores de adiposidad y metabólicos en población chilena – resultados del estudio GENADIO

Autores/as

  • Fanny Petermann-Rocha
  • Nicole Lasserre-Laso
  • Marcelo Villagrán
  • Lorena Mardones
  • María Adela Martínez
  • Ana María Leiva
  • Natalia Ulloa
  • Carlos Celis-Morales BHF Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow

Palabras clave:

Adiposity, Biomarkers, Diabetes Mellitus, Type 2, Genetics, Transcription Factor 7-Like 2 Protein

Resumen

Background: Type 2 diabetes etiology has a strong genetic component. More than 20 genetic variants have been associated with diabetes and other metabolic markers. However, the polymorphism rs7903146 of the TCF7L2 gene has shown the strongest association. Aim: To investigate the association of TCF7L2 (rs7903146) genotype with adiposity and metabolic markers in the Chilean adult population. Material and methods: The association of TCF7L2 (rs7093146) with adiposity and metabolic markers was studied in 301 participants. The outcomes of the study were adiposity markers (body weight, body mass index (BMI), fat mass and waist circumference) and metabolic markers (blood glucose, insulin, HOMA-IR, lipid profile, high sensitivity C-reactive protein (CRP), alanine aminotransferase (ALT), gamma glutamyl transpeptidase (GGT) and leptin). Results: There was an association between the polymorphism TCF7L2 genotype and fasting blood glucose. The latter increased by 4.86 mg/dl per each copy of the risk allele [(95% confidence intervals (CI): 0.48; 9.24), p=0.03] in the unadjusted adjusted model. However, this association was slightly attenuated in the fully adjusted model [4.38 mg/dl (95% IC: 0.16; 8.60), p=0.04). There were no associations between the TCF7L2 genotype and any other metabolic or adiposity outcome. Conclusions: These findings confirm the association between the TCF7L2 (rs7903146) and fasting glucose in the Chilean population. However, further studies are needed to confirm the association between the TCF7L2 and diabetes risk in the Chilean population.

Biografía del autor/a

Carlos Celis-Morales, BHF Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow

Carlos works as Associate Researchers at the BHF Glasgow Cardiovascular Research Centre in the Institute of Cardiovascular and Medical Science at the University of Glasgow. He is currently part of two multicentre research studies. The "STAND-UP" study, funded by the Medical Research Council, aims to investigate whether reduced sitting time through regular bouts of non-sedentary activity improves cardio-metabolic and cognitive health in older adults from white European and South Asian ethnic backgrounds. This project is a collaboration between the Universities of Leicester, Loughborough, Bedfordshire and Glasgow. In addition, Carlos has recently joined the research group headed by Prof Jill Pell working on the UK Biobank. UK Biobank is a prospective, population cohort study of 502,000 participants designed to determine the lifestyle, environmental and genetic factors that predispose to adult chronic diseases

Descargas

Publicado

2019-08-07

Cómo citar

Petermann-Rocha, F., Lasserre-Laso, N., Villagrán, M., Mardones, L., Martínez, M. A., Leiva, A. M., Ulloa, N., & Celis-Morales, C. (2019). Asociación del gen TCF7L2 (rs7903146) con marcadores de adiposidad y metabólicos en población chilena – resultados del estudio GENADIO. Revista Médica De Chile, 147(8). Recuperado a partir de https://mail.revistamedicadechile.cl/index.php/rmedica/article/view/6894

Número

Sección

Artículos de Investigación

Artículos más leídos del mismo autor/a

1 2 3 4 5 > >>